ALXN
Dimensional Fund Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-1,314,023
| Closed | -$241M | – | 3577 |
|
2021
Q2 | $241M | Sell |
1,314,023
-1,917
| -0.1% | -$352K | 0.08% | 267 |
|
2021
Q1 | $201M | Sell |
1,315,940
-4,337
| -0.3% | -$663K | 0.07% | 332 |
|
2020
Q4 | $206M | Sell |
1,320,277
-59,096
| -4% | -$9.23M | 0.07% | 273 |
|
2020
Q3 | $158M | Buy |
1,379,373
+24,456
| +2% | +$2.8M | 0.07% | 292 |
|
2020
Q2 | $152M | Buy |
1,354,917
+132,318
| +11% | +$14.8M | 0.07% | 293 |
|
2020
Q1 | $110M | Buy |
1,222,599
+390,878
| +47% | +$35.1M | 0.06% | 357 |
|
2019
Q4 | $89.9M | Buy |
831,721
+127,370
| +18% | +$13.8M | 0.03% | 812 |
|
2019
Q3 | $69M | Buy |
704,351
+69,567
| +11% | +$6.81M | 0.03% | 1037 |
|
2019
Q2 | $83.1M | Buy |
634,784
+985
| +0.2% | +$129K | 0.03% | 876 |
|
2019
Q1 | $85.7M | Sell |
633,799
-1,880
| -0.3% | -$254K | 0.03% | 810 |
|
2018
Q4 | $61.9M | Buy |
635,679
+95,895
| +18% | +$9.34M | 0.03% | 1001 |
|
2018
Q3 | $75M | Buy |
539,784
+145,649
| +37% | +$20.2M | 0.03% | 987 |
|
2018
Q2 | $48.9M | Buy |
394,135
+9,694
| +3% | +$1.2M | 0.02% | 1453 |
|
2018
Q1 | $42.9M | Buy |
384,441
+12,402
| +3% | +$1.38M | 0.02% | 1501 |
|
2017
Q4 | $44.5M | Buy |
372,039
+11,333
| +3% | +$1.36M | 0.02% | 1476 |
|
2017
Q3 | $50.6M | Sell |
360,706
-3,562
| -1% | -$500K | 0.02% | 1286 |
|
2017
Q2 | $44.3M | Buy |
364,268
+42,809
| +13% | +$5.21M | 0.02% | 1379 |
|
2017
Q1 | $39M | Buy |
321,459
+13,679
| +4% | +$1.66M | 0.02% | 1458 |
|
2016
Q4 | $37.7M | Buy |
307,780
+1,385
| +0.5% | +$169K | 0.02% | 1442 |
|
2016
Q3 | $37.5M | Buy |
306,395
+9,229
| +3% | +$1.13M | 0.02% | 1356 |
|
2016
Q2 | $34.7M | Sell |
297,166
-4,212
| -1% | -$492K | 0.02% | 1355 |
|
2016
Q1 | $41.9M | Buy |
301,378
+11,593
| +4% | +$1.61M | 0.03% | 1123 |
|
2015
Q4 | $55.3M | Buy |
289,785
+6,189
| +2% | +$1.18M | 0.03% | 763 |
|
2015
Q3 | $44.3M | Buy |
283,596
+3,448
| +1% | +$539K | 0.03% | 920 |
|
2015
Q2 | $50.6M | Buy |
280,148
+30,652
| +12% | +$5.54M | 0.03% | 852 |
|
2015
Q1 | $43.2M | Buy |
249,496
+16,925
| +7% | +$2.93M | 0.03% | 985 |
|
2014
Q4 | $43M | Buy |
232,571
+5,104
| +2% | +$944K | 0.03% | 907 |
|
2014
Q3 | $37.7M | Buy |
227,467
+14,107
| +7% | +$2.34M | 0.03% | 947 |
|
2014
Q2 | $33.3M | Buy |
213,360
+2,249
| +1% | +$351K | 0.02% | 1083 |
|
2014
Q1 | $32.1M | Buy |
211,111
+2,079
| +1% | +$316K | 0.02% | 1047 |
|
2013
Q4 | $27.8M | Buy |
209,032
+743
| +0.4% | +$98.9K | 0.02% | 1156 |
|
2013
Q3 | $24.2M | Buy |
208,289
+1,244
| +0.6% | +$144K | 0.02% | 1193 |
|
2013
Q2 | $19.1M | Buy |
+207,045
| New | +$19.1M | 0.02% | 1336 |
|